The global Albumin (as Excipient) revenue was US$ 4340.4 million in 2022 and is forecast to a readjusted size of US$ 6601.7 million by 2029 with a CAGR of 6.1% during the forecast period (2023-2029).

and India Albumin (as Excipient) Market

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

In India, the Albumin (as Excipient) revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.

By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.

This report focuses on global and India Albumin (as Excipient) market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Albumin (as Excipient) will continue to grow rapidly in the future.

Global Albumin (as Excipient) Scope and Market Size

Albumin (as Excipient) market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Albumin (as Excipient) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Albumin (as Excipient) market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Albumin (as Excipient) Market Report

Report Metric	Details
Report Name	and India Albumin (as Excipient) Market
Forecasted market size in 2029	US$ 6601.7 million
CAGR	6.1%
Forecasted years	2023 - 2029
Segment by Type	Human Serum Albumin Recombinant Albumin
Segment by Application	Cell Culture Media Medical Supplements Therapeutics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Albumedix, Biotest, Merck, Ventria (InVitria), HiMedia
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Albumin (as Excipient) Market size in 2029?

Ans: The and India Albumin (as Excipient) Market size in 2029 will be US$ 6601.7 million.

What is the Grifols share in and India Albumin (as Excipient) Market?

Ans: The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.

What is the and India Albumin (as Excipient) Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Albumin (as Excipient) Market report?

Ans: The main players in the and India Albumin (as Excipient) Market are CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Albumedix, Biotest, Merck, Ventria (InVitria), HiMedia

What are the Application segmentation covered in the and India Albumin (as Excipient) Market report?

Ans: The Applications covered in the and India Albumin (as Excipient) Market report are Cell Culture Media, Medical Supplements, Therapeutics

What are the Type segmentation covered in the and India Albumin (as Excipient) Market report?

Ans: The Types covered in the and India Albumin (as Excipient) Market report are Human Serum Albumin, Recombinant Albumin

1 Study Coverage

1.1 Albumin (as Excipient) Product Introduction

1.2 Global Albumin (as Excipient) Outlook 2018 VS 2022 VS 2029

1.2.1 Global Albumin (as Excipient) Sales in US$ Million for the Year 2018-2029

1.2.2 Global Albumin (as Excipient) Sales in Volume for the Year 2018-2029

1.3 India Albumin (as Excipient) Outlook 2018 VS 2022 VS 2029

1.3.1 India Albumin (as Excipient) Sales in US$ Million for the Year 2018-2029

1.3.2 India Albumin (as Excipient) Sales in Volume for the Year 2018-2029

1.4 Albumin (as Excipient) Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Albumin (as Excipient) in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Albumin (as Excipient) Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Albumin (as Excipient) Market Dynamics

1.5.1 Albumin (as Excipient) Industry Trends

1.5.2 Albumin (as Excipient) Market Drivers

1.5.3 Albumin (as Excipient) Market Challenges

1.5.4 Albumin (as Excipient) Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Albumin (as Excipient) by Type

2.1 Albumin (as Excipient) Market Segment by Type

2.1.1 Human Serum Albumin

2.1.2 Recombinant Albumin

2.2 Global Albumin (as Excipient) Market Size by Type

2.2.1 Global Albumin (as Excipient) Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Albumin (as Excipient) Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Albumin (as Excipient) Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Albumin (as Excipient) Market Size by Type

2.3.1 India Albumin (as Excipient) Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Albumin (as Excipient) Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Albumin (as Excipient) Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Albumin (as Excipient) by Application

3.1 Albumin (as Excipient) Market Segment by Application

3.1.1 Cell Culture Media

3.1.2 Medical Supplements

3.1.3 Therapeutics

3.2 Global Albumin (as Excipient) Market Size by Application

3.2.1 Global Albumin (as Excipient) Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Albumin (as Excipient) Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Albumin (as Excipient) Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Albumin (as Excipient) Market Size by Application

3.3.1 India Albumin (as Excipient) Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Albumin (as Excipient) Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Albumin (as Excipient) Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4 Global Albumin (as Excipient) Competitor Landscape by Company

4.1 Global Albumin (as Excipient) Market Size by Company

4.1.1 Global Key Manufacturers of Albumin (as Excipient), Ranked by Revenue (2022)

4.1.2 Global Albumin (as Excipient) Revenue by Manufacturer (2018-2023)

4.1.3 Global Albumin (as Excipient) Sales by Manufacturer (2018-2023)

4.1.4 Global Albumin (as Excipient) Price by Manufacturer (2018-2023)

4.2 Global Albumin (as Excipient) Concentration Ratio (CR)

4.2.1 Albumin (as Excipient) Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Albumin (as Excipient) in 2022

4.2.3 Global Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Albumin (as Excipient), Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Albumin (as Excipient), Product Offered and Application

4.5 Global Key Manufacturers of Albumin (as Excipient), Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Albumin (as Excipient) Market Size by Company

4.7.1 Key Players of Albumin (as Excipient) in India, Ranked by Revenue (2022)

4.7.2 India Albumin (as Excipient) Revenue by Players (2018-2023)

4.7.3 India Albumin (as Excipient) Sales by Players (2018-2023)

5 Global Albumin (as Excipient) Market Size by Region

5.1 Global Albumin (as Excipient) Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Albumin (as Excipient) Market Size in Volume by Region (2018-2029)

5.2.1 Global Albumin (as Excipient) Sales in Volume by Region: 2018-2023

5.2.2 Global Albumin (as Excipient) Sales in Volume Forecast by Region (2024-2029)

5.3 Global Albumin (as Excipient) Market Size in Value by Region (2018-2029)

5.3.1 Global Albumin (as Excipient) Sales in Value by Region: 2018-2023

5.3.2 Global Albumin (as Excipient) Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Albumin (as Excipient) Market Size YoY Growth 2018-2029

6.2 Americas Albumin (as Excipient) Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Albumin (as Excipient) Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Albumin (as Excipient) Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Albumin (as Excipient) Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Albumin (as Excipient) Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Albumin (as Excipient) Market Size YoY Growth 2018-2029

7.2 EMEA Albumin (as Excipient) Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Albumin (as Excipient) Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Albumin (as Excipient) Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Albumin (as Excipient) Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Albumin (as Excipient) Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Albumin (as Excipient) Market Size YoY Growth 2018-2029

8.2 China Albumin (as Excipient) Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Albumin (as Excipient) Sales in Volume, by Application (2018, 2022 & 2029)

9 APAC

9.1 APAC Albumin (as Excipient) Market Size YoY Growth 2018-2029

9.2 APAC Albumin (as Excipient) Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Albumin (as Excipient) Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Albumin (as Excipient) Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Albumin (as Excipient) Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Albumin (as Excipient) Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 CSL

10.1.1 CSL Company Information

10.1.2 CSL Description and Business Overview

10.1.3 CSL Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.1.4 CSL Albumin (as Excipient) Products Offered

10.1.5 CSL Recent Development

10.2 Grifols

10.2.1 Grifols Company Information

10.2.2 Grifols Description and Business Overview

10.2.3 Grifols Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Grifols Albumin (as Excipient) Products Offered

10.2.5 Grifols Recent Development

10.3 Takeda

10.3.1 Takeda Company Information

10.3.2 Takeda Description and Business Overview

10.3.3 Takeda Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Takeda Albumin (as Excipient) Products Offered

10.3.5 Takeda Recent Development

10.4 Octapharma

10.4.1 Octapharma Company Information

10.4.2 Octapharma Description and Business Overview

10.4.3 Octapharma Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Octapharma Albumin (as Excipient) Products Offered

10.4.5 Octapharma Recent Development

10.5 Hualan Bio

10.5.1 Hualan Bio Company Information

10.5.2 Hualan Bio Description and Business Overview

10.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Hualan Bio Albumin (as Excipient) Products Offered

10.5.5 Hualan Bio Recent Development

10.6 CBPO

10.6.1 CBPO Company Information

10.6.2 CBPO Description and Business Overview

10.6.3 CBPO Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.6.4 CBPO Albumin (as Excipient) Products Offered

10.6.5 CBPO Recent Development

10.7 Shanghai RAAS

10.7.1 Shanghai RAAS Company Information

10.7.2 Shanghai RAAS Description and Business Overview

10.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Shanghai RAAS Albumin (as Excipient) Products Offered

10.7.5 Shanghai RAAS Recent Development

10.8 Kedrion

10.8.1 Kedrion Company Information

10.8.2 Kedrion Description and Business Overview

10.8.3 Kedrion Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Kedrion Albumin (as Excipient) Products Offered

10.8.5 Kedrion Recent Development

10.9 LFB Group

10.9.1 LFB Group Company Information

10.9.2 LFB Group Description and Business Overview

10.9.3 LFB Group Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.9.4 LFB Group Albumin (as Excipient) Products Offered

10.9.5 LFB Group Recent Development

10.10 Albumedix

10.10.1 Albumedix Company Information

10.10.2 Albumedix Description and Business Overview

10.10.3 Albumedix Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Albumedix Albumin (as Excipient) Products Offered

10.10.5 Albumedix Recent Development

10.11 Biotest

10.11.1 Biotest Company Information

10.11.2 Biotest Description and Business Overview

10.11.3 Biotest Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.11.4 Biotest Albumin (as Excipient) Products Offered

10.11.5 Biotest Recent Development

10.12 Merck

10.12.1 Merck Company Information

10.12.2 Merck Description and Business Overview

10.12.3 Merck Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.12.4 Merck Albumin (as Excipient) Products Offered

10.12.5 Merck Recent Development

10.13 Ventria (InVitria)

10.13.1 Ventria (InVitria) Company Information

10.13.2 Ventria (InVitria) Description and Business Overview

10.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.13.4 Ventria (InVitria) Albumin (as Excipient) Products Offered

10.13.5 Ventria (InVitria) Recent Development

10.14 HiMedia

10.14.1 HiMedia Company Information

10.14.2 HiMedia Description and Business Overview

10.14.3 HiMedia Albumin (as Excipient) Sales, Revenue and Gross Margin (2018-2023)

10.14.4 HiMedia Albumin (as Excipient) Products Offered

10.14.5 HiMedia Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Albumin (as Excipient) Industry Chain Analysis

11.2 Albumin (as Excipient) Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Albumin (as Excipient) Production Mode & Process

11.4 Albumin (as Excipient) Sales and Marketing

11.4.1 Albumin (as Excipient) Sales Channels

11.4.2 Albumin (as Excipient) Distributors

11.5 Albumin (as Excipient) Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Albumin (as Excipient) CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Albumin (as Excipient) Market Trends

Table 3. Albumin (as Excipient) Market Drivers

Table 4. Albumin (as Excipient) Market Challenges

Table 5. Albumin (as Excipient) Market Restraints

Table 6. Global Albumin (as Excipient) Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Albumin (as Excipient) Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Albumin (as Excipient) Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Albumin (as Excipient) Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Albumin (as Excipient), Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Albumin (as Excipient) Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Albumin (as Excipient) Revenue Share by Manufacturer, 2018-2023

Table 13. Global Albumin (as Excipient) Sales by Manufacturer, (MT), 2018-2023

Table 14. Global Albumin (as Excipient) Sales Share by Manufacturer, 2018-2023

Table 15. Global Albumin (as Excipient) Price by Manufacturer (2018-2023) & (USD/Kg)

Table 16. Global Albumin (as Excipient) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Albumin (as Excipient) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albumin (as Excipient) as of 2022)

Table 18. Global Key Manufacturers of Albumin (as Excipient), Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Albumin (as Excipient), Product Offered and Application

Table 20. Global Key Manufacturers of Albumin (as Excipient), Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Albumin (as Excipient) in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Albumin (as Excipient) Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Albumin (as Excipient) Revenue Share by Players, (2018-2023)

Table 25. India Albumin (as Excipient) Sales by Players, (MT), (2018-2023)

Table 26. India Albumin (as Excipient) Sales Share by Players, (2018-2023)

Table 27. Global Albumin (as Excipient) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Albumin (as Excipient) Sales in Volume by Region (2018-2023) & (MT)

Table 29. Global Albumin (as Excipient) Sales in Volume Forecast by Region (2024-2029) & (MT)

Table 30. Global Albumin (as Excipient) Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Albumin (as Excipient) Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Albumin (as Excipient) Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Albumin (as Excipient) Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Albumin (as Excipient) Sales in Volume by Country (2018-2023) & (MT)

Table 36. Americas Albumin (as Excipient) Sales in Volume by Country (2024-2029) & (MT)

Table 37. EMEA Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Albumin (as Excipient) Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Albumin (as Excipient) Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Albumin (as Excipient) Sales in Volume by Country (2018-2023) & (MT)

Table 41. EMEA Albumin (as Excipient) Sales in Volume by Country (2024-2029) & (MT)

Table 42. APAC Albumin (as Excipient) Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Albumin (as Excipient) Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Albumin (as Excipient) Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Albumin (as Excipient) Sales in Volume by Country (2018-2023) & (MT)

Table 46. APAC Albumin (as Excipient) Sales in Volume by Country (2024-2029) & (MT)

Table 47. CSL Company Information

Table 48. CSL Description and Business Overview

Table 49. CSL Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 50. CSL Albumin (as Excipient) Product

Table 51. CSL Recent Development

Table 52. Grifols Company Information

Table 53. Grifols Description and Business Overview

Table 54. Grifols Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 55. Grifols Albumin (as Excipient) Product

Table 56. Grifols Recent Development

Table 57. Takeda Company Information

Table 58. Takeda Description and Business Overview

Table 59. Takeda Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 60. Takeda Albumin (as Excipient) Product

Table 61. Takeda Recent Development

Table 62. Octapharma Company Information

Table 63. Octapharma Description and Business Overview

Table 64. Octapharma Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 65. Octapharma Albumin (as Excipient) Product

Table 66. Octapharma Recent Development

Table 67. Hualan Bio Company Information

Table 68. Hualan Bio Description and Business Overview

Table 69. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 70. Hualan Bio Albumin (as Excipient) Product

Table 71. Hualan Bio Recent Development

Table 72. CBPO Company Information

Table 73. CBPO Description and Business Overview

Table 74. CBPO Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 75. CBPO Albumin (as Excipient) Product

Table 76. CBPO Recent Development

Table 77. Shanghai RAAS Company Information

Table 78. Shanghai RAAS Description and Business Overview

Table 79. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 80. Shanghai RAAS Albumin (as Excipient) Product

Table 81. Shanghai RAAS Recent Development

Table 82. Kedrion Company Information

Table 83. Kedrion Description and Business Overview

Table 84. Kedrion Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 85. Kedrion Albumin (as Excipient) Product

Table 86. Kedrion Recent Development

Table 87. LFB Group Company Information

Table 88. LFB Group Description and Business Overview

Table 89. LFB Group Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 90. LFB Group Albumin (as Excipient) Product

Table 91. LFB Group Recent Development

Table 92. Albumedix Company Information

Table 93. Albumedix Description and Business Overview

Table 94. Albumedix Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 95. Albumedix Albumin (as Excipient) Product

Table 96. Albumedix Recent Development

Table 97. Biotest Company Information

Table 98. Biotest Description and Business Overview

Table 99. Biotest Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 100. Biotest Albumin (as Excipient) Product

Table 101. Biotest Recent Development

Table 102. Merck Company Information

Table 103. Merck Description and Business Overview

Table 104. Merck Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 105. Merck Albumin (as Excipient) Product

Table 106. Merck Recent Development

Table 107. Ventria (InVitria) Company Information

Table 108. Ventria (InVitria) Description and Business Overview

Table 109. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 110. Ventria (InVitria) Albumin (as Excipient) Product

Table 111. Ventria (InVitria) Recent Development

Table 112. HiMedia Company Information

Table 113. HiMedia Description and Business Overview

Table 114. HiMedia Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 115. HiMedia Albumin (as Excipient) Product

Table 116. HiMedia Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Albumin (as Excipient) Customers List

Table 120. Albumin (as Excipient) Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Albumin (as Excipient) Product Picture

Figure 2. Global Albumin (as Excipient) Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Albumin (as Excipient) Market Size 2018-2029 (US$ Million)

Figure 4. Global Albumin (as Excipient) Sales 2018-2029 (MT)

Figure 5. India Albumin (as Excipient) Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Albumin (as Excipient) Market Size 2018-2029 (US$ Million)

Figure 7. India Albumin (as Excipient) Sales 2018-2029 (MT)

Figure 8. India Albumin (as Excipient) Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Albumin (as Excipient) Market Share in Global, in Volume (MT) 2018-2029

Figure 10. Albumin (as Excipient) Report Years Considered

Figure 11. Product Picture of Human Serum Albumin

Figure 12. Product Picture of Recombinant Albumin

Figure 13. Global Albumin (as Excipient) Market Share by Type in 2022 & 2029

Figure 14. Global Albumin (as Excipient) Sales in Value by Type (2018-2029) & (US$ Million)

Figure 15. Global Albumin (as Excipient) Sales Market Share in Value by Type (2018-2029)

Figure 16. Global Albumin (as Excipient) Sales by Type (2018-2029) & (MT)

Figure 17. Global Albumin (as Excipient) Sales Market Share in Volume by Type (2018-2029)

Figure 18. Global Albumin (as Excipient) Price by Type (2018-2029) & (USD/Kg)

Figure 19. India Albumin (as Excipient) Market Share by Type in 2022 & 2029

Figure 20. India Albumin (as Excipient) Sales in Value by Type (2018-2029) & (US$ Million)

Figure 21. India Albumin (as Excipient) Sales Market Share in Value by Type (2018-2029)

Figure 22. India Albumin (as Excipient) Sales by Type (2018-2029) & (MT)

Figure 23. India Albumin (as Excipient) Sales Market Share in Volume by Type (2018-2029)

Figure 24. India Albumin (as Excipient) Price by Type (2018-2029) & (USD/Kg)

Figure 25. Product Picture of Cell Culture Media

Figure 26. Product Picture of Medical Supplements

Figure 27. Product Picture of Therapeutics

Figure 28. Global Albumin (as Excipient) Market Share by Application in 2022 & 2029

Figure 29. Global Albumin (as Excipient) Sales in Value by Application (2018-2029) & (US$ Million)

Figure 30. Global Albumin (as Excipient) Sales Market Share in Value by Application (2018-2029)

Figure 31. Global Albumin (as Excipient) Sales by Application (2018-2029) & (MT)

Figure 32. Global Albumin (as Excipient) Sales Market Share in Volume by Application (2018-2029)

Figure 33. Global Albumin (as Excipient) Price by Application (2018-2029) & (USD/Kg)

Figure 34. India Albumin (as Excipient) Market Share by Application in 2022 & 2029

Figure 35. India Albumin (as Excipient) Sales in Value by Application (2018-2029) & (US$ Million)

Figure 36. India Albumin (as Excipient) Sales Market Share in Value by Application (2018-2029)

Figure 37. India Albumin (as Excipient) Sales by Application (2018-2029) & (MT)

Figure 38. India Albumin (as Excipient) Sales Market Share in Volume by Application (2018-2029)

Figure 39. India Albumin (as Excipient) Price by Application (2018-2029) & (USD/Kg)

Figure 40. Americas Albumin (as Excipient) Sales in Volume Growth Rate 2018-2029 (MT)

Figure 41. Americas Albumin (as Excipient) Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 42. Americas Albumin (as Excipient) Sales by Type (2018-2029) & (MT)

Figure 43. Americas Albumin (as Excipient) Sales Market Share in Volume by Type (2018-2029)

Figure 44. Americas Albumin (as Excipient) Sales by Application (2018-2029) & (MT)

Figure 45. Americas Albumin (as Excipient) Sales Market Share in Volume by Application (2018-2029)

Figure 46. United States Albumin (as Excipient) Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 47. Canada Albumin (as Excipient) Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 48. Mexico Albumin (as Excipient) Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 49. Brazil Albumin (as Excipient) Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 50. EMEA Albumin (as Excipient) Sales in Volume Growth Rate 2018-2029 (MT)

Figure 51. EMEA Albumin (as Excipient) Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 52. EMEA Albumin (as Excipient) Sales by Type (2018-2029) & (MT)

Figure 53. EMEA Albumin (as Excipient) Sales Market Share in Volume by Type (2018-2029)

Figure 54. EMEA Albumin (as Excipient) Sales by Application (2018-2029) & (MT)

Figure 55. EMEA Albumin (as Excipient) Sales Market Share in Volume by Application (2018-2029)

Figure 56. Europe Albumin (as Excipient) Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 57. Middle East Albumin (as Excipient) Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 58. Africa Albumin (as Excipient) Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 59. China Albumin (as Excipient) Sales in Volume Growth Rate 2018-2029 (MT)

Figure 60. China Albumin (as Excipient) Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 61. China Albumin (as Excipient) Sales by Type (2018-2029) & (MT)

Figure 62. China Albumin (as Excipient) Sales Market Share in Volume by Type (2018-2029)

Figure 63. China Albumin (as Excipient) Sales by Application (2018-2029) & (MT)

Figure 64. China Albumin (as Excipient) Sales Market Share in Volume by Application (2018-2029)

Figure 65. APAC Albumin (as Excipient) Sales in Volume Growth Rate 2018-2029 (MT)

Figure 66. APAC Albumin (as Excipient) Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 67. APAC Albumin (as Excipient) Sales by Type (2018-2029) & (MT)

Figure 68. APAC Albumin (as Excipient) Sales Market Share in Volume by Type (2018-2029)

Figure 69. APAC Albumin (as Excipient) Sales by Application (2018-2029) & (MT)

Figure 70. APAC Albumin (as Excipient) Sales Market Share in Volume by Application (2018-2029)

Figure 71. Japan Albumin (as Excipient) Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 72. South Korea Albumin (as Excipient) Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 73. China Taiwan Albumin (as Excipient) Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 74. Southeast Asia Albumin (as Excipient) Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 75. India Albumin (as Excipient) Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 76. Albumin (as Excipient) Value Chain

Figure 77. Albumin (as Excipient) Production Process

Figure 78. Channels of Distribution

Figure 79. Distributors Profiles

Figure 80. Bottom-up and Top-down Approaches for This Report

Figure 81. Data Triangulation

Figure 82. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions